BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Stefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, Giampiero Francica, Amedeo Lonardo. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complicationsExpert Review of Gastroenterology & Hepatology 2015; 9(5): 603 doi: 10.1586/17474124.2015.1007955
2
Patrik Nasr, Annette Hilliges, Lars Thorelius, Stergios Kechagias, Mattias Ekstedt. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver diseaseScandinavian Journal of Gastroenterology 2016; 51(9): 1126 doi: 10.3109/00365521.2016.1172336
3
Harshul Pandit, Joseph P. Tinney, Yan Li, Guozhen Cui, Suping Li, Bradley B. Keller, Robert C.G. Martin. Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse ModelsUltrasound in Medicine & Biology 2019; 45(2): 549 doi: 10.1016/j.ultrasmedbio.2018.10.011
4
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
5
Sarit Anavi, Zecharia Madar, Oren Tirosh. Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty liversRedox Biology 2017; 13: 386 doi: 10.1016/j.redox.2017.06.008
6
C. Pozzessere, K.K. Porter, I.R. Kamel. Surveillance liver MRI for monitoring patients with known or suspected chronic liver diseaseClinical Radiology 2017; 72(1): 93.e7 doi: 10.1016/j.crad.2016.08.009
7
Hyun Joo Shin, Eun Young Chang, Hye Sun Lee, Jung Hwa Hong, Gyuri Park, Hyun Gi Kim, Myung-Joon Kim, Mi-Jung Lee. Contrast-enhanced ultrasonography for the evaluation of liver fibrosis after biliary obstructionWorld Journal of Gastroenterology 2015; 21(9): 2614-2621 doi: 10.3748/wjg.v21.i9.2614
8
Ryan E. Childers, Joseph Ahn. Diagnosis of Alcoholic Liver DiseaseClinics in Liver Disease 2016; 20(3): 457 doi: 10.1016/j.cld.2016.02.005
9
Jiqing Xuan, Yuli Chen, Leilei Zhu, Yuan Guo, Liming Deng, Yuanyi Zheng, Zhaoxia Wang, Zhigang Wang, Meng Ao. Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat modelOncotarget 2017; 8(65): 108676 doi: 10.18632/oncotarget.21358
10
Jiajia Yang, Liwu Lin, Ensheng Xue, Dengke Hong, Yan Yang, Meifang Xu, Zhikui Chen. Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging?Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/2013674
11
Chimeddulam Dalaijamts, Joseph A. Cichocki, Yu-Syuan Luo, Ivan Rusyn, Weihsueh A. Chiu. PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in miceToxicology and Applied Pharmacology 2020; 400: 115069 doi: 10.1016/j.taap.2020.115069
12
Bo Zhang, Fang Ding, Tian Chen, Liang-Hua Xia, Juan Qian, Guo-Yi Lv. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat contentWorld Journal of Gastroenterology 2014; 20(47): 17985-17992 doi: 10.3748/wjg.v20.i47.17985